Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Organovo Holdings Inc    ONVO

ORGANOVO HOLDINGS INC (ONVO)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
1.03(c) 1.13(c) 1.19(c) 1.12(c) 1.18(c) Last
600 367 1 895 846 1 712 301 1 066 213 800 275 Volume
+1.98% +9.71% +5.31% -5.88% +5.36% Change
More quotes
Financials (USD)
Sales 2018 4,83 M
EBIT 2018 -35,9 M
Net income 2018 -36,0 M
Debt 2018 -
Yield 2018 -
Sales 2019 8,07 M
EBIT 2019 -33,7 M
Net income 2019 -34,7 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 27,1x
Capi. / Sales2019 16,2x
Capitalization 131 M
More Financials
Company
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications.It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be... 
More about the company
Surperformance© ratings of Organovo Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ORGANOVO HOLDINGS INC
04/16Organovo Achieves Key Development Milestones for Its Liver Disease and Intest..
GL
04/12Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Li..
GL
04/12CIRIUS THERAPEUTICS : ' Preclinical Data Demonstrates Potential for Lead Drug Ca..
PR
03/26Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With..
GL
03/19ORGANOVO HOLDINGS, INC. (NASDAQ : ONVO) Files An 8-K Entry into a Material Defin..
AQ
03/16ORGANOVO HOLDINGS, INC. : Entry into a Material Definitive Agreement, Terminatio..
AQ
03/16ORGANOVO : to Present at H.C. Wainwright Nash Investor Conference
AQ
03/15Organovo to Present at H.C. Wainwright Nash Investor Conference
GL
03/08Organovo to Present at 30th Annual ROTH Conference
GL
02/09FRIDAY SECTOR LAGGARDS : Precious Metals, Biotechnology Stocks
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
04/21$1.33 Million in Sales Expected for Organovo $ONVO This Quarter  
04/20$SVSA 062 CRUSHED .07 UP HETE WE GO!!! 83 MILLION IN ASSETS 4.4 MILLION IN CA.. 
04/18Organovo $ONVO Receiving Somewhat Favorable News Coverage, Accern Reports  
04/18$NSPX 02?! STOCK CANCER PATENT $1 RUN COMING? ur @ the right place RIGHT TIM..
6
04/18Organovo Holdings Inc $ONVO Expected to Post Quarterly Sales of $1.33 Million.. 
More tweets
Qtime:181
News from SeekingAlpha
04/153 THINGS IN BIOTECH, APRIL 14 : Organovo, Catalyst, And Aeglea Open Up 
03/26Organovo inks distribution deal with Lonza Bioscience; shares up 10% premarke.. 
03/16Key events next week - healthcare 
03/09Key events next week - healthcare 
02/09HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (2/9/2018) 
Chart ORGANOVO HOLDINGS INC
Duration : Period :
Organovo Holdings Inc Technical Analysis Chart | ONVO | US68620A1043 | 4-Traders
Technical analysis trends ORGANOVO HOLDINGS INC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2,50 $
Spread / Average Target 112%
EPS Revisions
Managers
NameTitle
Taylor J. Crouch President, Chief Executive Officer & Director
Kirk D. Malloy Chairman
Craig S. Kussman Chief Financial Officer
Sharon Collins Presnell Chief Scientific Officer
James T. Glover Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORGANOVO HOLDINGS INC-11.94%131
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.09%14 493
NEKTAR THERAPEUTICS44.36%13 873